Laura Joszt, MA

Higher levels of activity were associated with a significantly lowered risk for outcomes in 5 common chronic diseases; however, the largest gains were made at lower levels of activity with diminishing gains as activity levels increased.

Health insurance status can have a big impact on a person’s health outcomes after they are diagnosed with cancer, according to 2 new studies published in CANCER.

In an attempt to appease the Department of Justice and save their proposed merger, Aetna and Humana make deals to sell certain Medicare Advantage assets to Molina Healthcare.

Consumers on the Affordable Care Act's public exchanges have shown a willingness to shop around for coverage that heath plans can tap into.

A new study, presented at the 2016 Alzheimer’s Association International Conference, suggested that treating people with Alzheimer’s disease may increase survival and reduce cost, even though the treatment does not change the underlying course of the disease.

As the healthcare industry moves from volume to value, new healthcare delivery models are being tested and promoted, and CMS has put a lot of faith into the accountable care organization. So has Aledade.

The way the meaningful use program was structured was more about the adoption of electronic health records and not interoperability, and in order to get there, the US health system needs to first understand what it wants interoperability to do.

Making medical decisions is not as easy as following the evidence. When dealing with people, there are a number of anomalies that influence the decisions someone might make.

UnitedHealth Group is suing American Renal Associates Holdings for fraudulent behavior, and Anthem and Express Scripts are facing a lawsuit for overcharging on prescription drugs.

In the last 5 years urgent care has seen a rise in popularity. Here are 5 facts about urgent care clinics.

When the topic of affordability of healthcare comes up, people usually mean the price of healthcare, but there is a difference, said Tomas Philipson, PhD, of the University of Chicago, at the ISPOR Annual Meeting.

The rising cost of drugs is a cause for concern among various stakeholders in healthcare, some of who worry that staying on the current trajectory will “break the bank,” said panelists during a session at the ISPOR Annual Meeting.

At the Pharmacy Quality Alliance's Annual Meeting, Kate Goodrich, MD, of CMS, and a group of experts discussed the government's move toward value-based care and the use of quality measures.

HHS and the Department of Justice announced a nationwide sweep led by the Medicare Fraud Strike Force resulting in charges against 301 individuals for their alleged participation in healthcare fraud schemes involving $900 million in false billings.

The Department of Justice has found that the Nevada Department of Corrections has been discriminating against inmates with HIV and with disabilities, according to a letter of findings issued.

Addressing the unmet social needs of patients requires additional investment on the part of the healthcare industry, but provides a tangible return on investment.

Coverage from the 2016 Spring Live Meeting of the ACO & Emerging Healthcare Delivery Coalition on April 28-29, 2016, in Scottsdale, Arizona.

The Supreme Court ruled to uphold a new process for challenging patents that the pharmaceutical industry was hoping would be struck down. Generic drug companies and health insurance plans supported the new rule, which could help lower prices.

The healthcare ecosystem can be a very complex place, and it’s important to remember that a patient sits at the center, explained David M. Cordani, president and CEO of Cigna Corp., during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo.

As America’s Health Insurance Plans’ Institute & Expo kicked off in Las Vegas on June 15, Susan Dentzer, president and CEO of The Network for Excellence in Health Innovation, moderated a panel discussion on the possibility of delivery better healthcare at a lower cost.

Healthcare leaders and experts will come together to discuss disruptors, consumer engagement, digital health, and more at the AHIP Institute & Expo, being held June 15-17 in Las Vegas.

A new analysis from The Commonwealth Fund has found that the Cadillac tax will likely be more progressive than initially thought.

States are taking the lead in the fight against rising drug prices. Vermont has passed legislation to regulate yearly drug price hikes and other states have introduced similar legislation.

New hepatitis C virus treatments may be extraordinarily effective, curing the disease in many cases, but the high cost has posed an enormous economic challenge that speakers outlined during a briefing in Washington, DC.

Access to care remains an issue for many US veterans, but a new initiative between the Department of Veterans Affairs Palo Alto Health Care System and MinuteClinic could expand access to care in Northern California.

One year after being hospitalized for heart failure, one-third of patients had not returned to work, according to a study presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

Value, cost, and the patient are taking center stage during the ISPOR 21st Annual International Meeting, which is being held May 21-25, 2016, in Washington, DC.

Researchers set out to analyze the clinical outcomes in a real-world clinical setting of patients with T2D who switched to Toujeo from another basal insulin.

Survival rates increase as more quality measures are incorporated into care, but only 13% of eligible patients with Stage IIIA non-small cell lung cancer actually receive all 4 measures.

Over the last year, The American Journal of Managed Care has covered many aspects of the hepatitis C issue: access to treatment, the cost of drugs, exclusivity deals, and more. Here are the most-read articles from the last year.